A team of scientists from Icahn School of Medicine at Mount Sinai has developed a groundbreaking statistical technique, “BridgePRS,” to enhance disease prediction in people of non-European ancestry, particularly those of African descent. This development represents a substantial step towards reducing health care inequities and a future of more personalized and precise medical interventions based on genetic information. Details of their work were published in Nature Genetics on Wednesday, December 20.